TW201129374A - Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia - Google Patents

Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia

Info

Publication number
TW201129374A
TW201129374A TW099135861A TW99135861A TW201129374A TW 201129374 A TW201129374 A TW 201129374A TW 099135861 A TW099135861 A TW 099135861A TW 99135861 A TW99135861 A TW 99135861A TW 201129374 A TW201129374 A TW 201129374A
Authority
TW
Taiwan
Prior art keywords
ataxia
treatment
friedreich
carbamylated erythropoietin
carbamylated
Prior art date
Application number
TW099135861A
Other languages
Chinese (zh)
Inventor
Lars Torup
Barbara Scheiber-Mojdehkar
Yurika Maria Katsu Jimenez
Javier Diaz-Nido
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TW201129374A publication Critical patent/TW201129374A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to carbamylated erythropoietin for use in the treatment of Frie-drich's ataxia.
TW099135861A 2009-10-26 2010-10-21 Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia TW201129374A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200901154 2009-10-26
DKPA201000790 2010-09-06

Publications (1)

Publication Number Publication Date
TW201129374A true TW201129374A (en) 2011-09-01

Family

ID=43921366

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099135861A TW201129374A (en) 2009-10-26 2010-10-21 Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia

Country Status (3)

Country Link
AR (1) AR078765A1 (en)
TW (1) TW201129374A (en)
WO (1) WO2011050808A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040091961A1 (en) 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
EP1633305A2 (en) * 2003-05-19 2006-03-15 The Kenneth S. Warren Institute, Inc. Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
EA011586B1 (en) 2004-07-07 2009-04-28 Х. Лундбекк А/С Novel carbamylated epo and method for its production
AT500929B1 (en) 2004-11-09 2007-03-15 Medizinische Uni Wien Muw PHARMACEUTICAL PREPARATION CONTAINING ERYTHROPOIETIN

Also Published As

Publication number Publication date
WO2011050808A1 (en) 2011-05-05
AR078765A1 (en) 2011-11-30

Similar Documents

Publication Publication Date Title
MX2014010455A (en) Methods and compositions for treating huntington's disease.
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
MX2012007098A (en) Phenol derivatives and pharmaceutical or cosmetic use thereof.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX2012007161A (en) Phenol derivatives and pharmaceutical or cosmetic use thereof.
MX2010001865A (en) Personal care compositions comprising dye-polymer complexes.
BRPI1007603A2 (en) "hair treatment composition"
HK1159659A1 (en) Treatment of autoimmune disease by modulating annexin-1 (lipocortin 1) -i( i)
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
EP2515926A4 (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
MX342947B (en) Treatment of type 2 diabetes.
MX359181B (en) Collagen hydrolysate and use thereof.
BR112012025270A2 (en) "personal care composition"
EP2404592A4 (en) Hair treatment composition
PT2611457E (en) Compositions and methods for treating friedreich's ataxia with interferon gamma
EP2707486A4 (en) Diagnosis and treatment of friedreich's ataxia
SG191060A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
IN2014DN07326A (en)
IN2014MN01733A (en)
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
ZA201105125B (en) Hair treatment composition
IN2012DN03096A (en)
UA106490C2 (en) Use of propineb as bird repellent
EP2594579A4 (en) Truncated human papillomavirus type 58 l1 protein
BR112012003653A2 (en) "method of treating cancer."